David Surguladze

David Surguladze

UNVERIFIED PROFILE

Are you David Surguladze?   Register this Author

Register author
David Surguladze

David Surguladze

Publications by authors named "David Surguladze"

Are you David Surguladze?   Register this Author

18Publications

751Reads

46Profile Views

Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models.

Anticancer Res 2009 Jun;29(6):1999-2007

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, New York, NY10014, U.S.A.

View Article

Download full-text PDF

Source
June 2009